Methods for directed differentiation of pluripotent stem cells to immune cells
US12129486B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2020 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Aug 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for the efficient in vitro differentiation of somatic cell-derived pluripotent stem cells to hematopoietic precursor cells, and the further differentiation of the hematopoietic precursor cells into immune cells of various myeloid or lymphoid lineages, particularly T cells, NK cells, and dendritic cells. The pluripotent cells may be maintained and differentiated under defined conditions; thus, the use of mouse feeder cells or serum is not required in certain embodiments for the differentiation of the hematopoietic precursor cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.